Replimune Group, Inc.·4

Feb 20, 4:15 PM ET

Astley-Sparke Philip 4

4 · Replimune Group, Inc. · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Replimune Director Philip Astley-Sparke Gifts 25,000 Shares

What Happened
Philip Astley-Sparke, a director of Replimune Group, Inc. (REPL), reported a gift disposition of 25,000 common shares on February 18, 2026. The Form 4 shows the transaction code G (gift), a reported price of $0.00 per share and $0 total proceeds — indicating the shares were transferred as a gift rather than sold for cash.

Key Details

  • Transaction date: 2026-02-18; Form 4 filed: 2026-02-20 (timely filing).
  • Transaction type/code: Gift (G) — disposition of 25,000 shares.
  • Price/proceeds: $0.00 per share; $0 reported proceeds.
  • Shares owned after transaction: Not specified in the summary provided — see the full Form 4 for post-transaction holdings.
  • Footnotes/plan mentions: None disclosed in the provided summary (no 10b5-1, tax withholding, or immediate sale noted).

Context
Gifts are transfers for estate planning, charitable, or personal reasons and do not necessarily indicate the insider’s view of the company’s prospects. For investing decisions, purchases or open-market sales typically carry more direct informational weight. Retail investors should review the full Form 4 for beneficiary details or additional notes and watch for any subsequent insider trades.

Insider Transaction Report

Form 4
Period: 2026-02-18
Transactions
  • Gift

    Common Stock

    2026-02-1825,0001,380,071 total
Signature
/s/ Shawn Glidden, attorney-in-fact|2026-02-20

Documents

1 file
  • 4
    tm266938-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT